A personalized absorbable tissue isolation system and its preparation method and application

Through a personalized absorbable tissue isolation system, the tissue isolation plate prepared with degradable materials is designed in combination with the membrane, which solves the problem that foreign fixing materials in the repair of alveolar bone defects and is difficult to maintain the bone formation space, achieving stable mechanical support and no need for secondary Complete degradation of the surgery improves the alveolar bone regeneration effect and patient safety.

CN118526647BActive Publication Date: 2024-11-22SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411011421.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-07-26
Publication Date
2024-11-22
Estimated Expiration
2044-07-26

AI Technical Summary

Technical Problem

In the existing alveolar bone defect repair technology, external fixation materials are difficult to stabilize and maintain the osteogenesis space, resulting in unsatisfactory bone incremental effect. In addition, traditional materials may cause mucosal irritation and secondary trauma during the degradation process, increasing the risk of surgery.

Method used

Using a personalized absorbable tissue isolation system, the tissue isolation plate prepared by degradable materials is designed with the membrane, and the tissue isolation plate is used to provide stable support. The tissue isolation membrane participates in osteogenesis, and the hydrophilicity and adhesion of the material are enhanced by plasma treatment. Achieve complete degradation and absorption after bone defect healing.

Benefits of technology

Maintain stable mechanical support during alveolar bone regeneration, avoid postoperative complications, achieve complete degradation without secondary surgery, and improve bone tissue regeneration effect and patient safety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118526647B_ABST
    Figure CN118526647B_ABST
Patent Text Reader

Abstract

The present invention provides a personalized absorbable tissue isolation system and a preparation method and application thereof, wherein the personalized absorbable tissue isolation system includes a tissue isolation plate and a tissue isolation membrane, the tissue isolation membrane is attached to the surface of the tissue isolation plate close to the bone, the tissue isolation plate is mainly made of medical degradable materials, and the tissue isolation membrane is prepared by mixing medical degradable materials with osteogenic active materials; the glass transition temperature of the personalized absorbable tissue isolation system is 40-60°C. The present invention creatively combines the plate and membrane made of degradable materials to achieve both stable support and tissue isolation. The isolation system provided by the present invention is structurally designed based on clinical needs, which is convenient for the operator to fix during surgery. At the same time, during surgery, the guide plate can be arbitrarily shaped and cut according to the patient's condition to fit the tissue and avoid complications caused by unstable fitting after surgery.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of oral medical materials, and in particular relates to a personalized absorbable tissue isolation system and a preparation method and application thereof. Background Art

[0002] Alveolar bone defects are common in clinical practice, mainly caused by congenital malformations, trauma, tumors, inflammation, etc. When the amount of bone defects reaches a critical value, the human body cannot repair it by itself, which will seriously affect daily chewing, language function, aesthetics, and the success of dental implant surgery. The Guided Bone Regeneration (GBR) technology in oral transplantation can effectively increase bone volume and restore the height and fullness of the alveolar bone. In current clinical operations, this technology mainly uses natural bone powder or artificial bone powder as filling, supplemented by external fixation materials. Commonly used external fixation materials are mainly absorbable (or non-absorbable) barrier membranes or metal titanium meshes, which are fixed with sutures or membrane nails.

[0003] However, when facing large bone tissue defects, the bone augmentation effect of GBR technology using traditional external fixation materials is not ideal. The main reasons are: the powder filler is squeezed by soft tissue and the self-dissolution process is uneven, and the shape is prone to collapse. It is difficult to ensure a stable bone formation space using existing absorbable or non-absorbable barrier membranes, resulting in unstable effects in repairing alveolar bone thickness and alveolar ridge height, and even requiring secondary bone grafting. In addition, the degradation time and degree of absorbable barrier membranes are difficult to predict. The vertical GBR healing time is usually 6-9 months, while the commonly used collagen membranes are mostly degraded in 4-6 weeks. The premature absorption of the membrane leads to the loss of its mechanical strength and the ability to maintain bone formation space, and causes fibrous tissue to grow inward, thereby interfering with bone regeneration in the surgical area.

[0004] In order to stably maintain the osteogenic space in the larger bone tissue defect, titanium mesh is usually used clinically to provide mechanical support for the osteogenic space. The outer surface is covered with an absorbable membrane and fixed with sutures or membrane nails to complete the GBR bone grafting surgery. However, the surface of the titanium mesh is not suitable for tissue adhesion, and the changes in material stiffness and sharp edges caused by trimming the contour are likely to cause mucosal irritation, which may lead to the failure of the mucoperiosteal flap to achieve complete coverage after implantation, and the exposure rate of the titanium mesh under the mucosa is high after surgery, and even gum atrophy may occur; secondly, titanium metal fixation is non-degradable, which will cause secondary trauma during the postoperative removal process, increasing the risk of surgery; moreover, the higher Young's modulus of titanium metal is likely to produce a stress shielding effect, which hinders osteoblast differentiation.

[0005] Degradable metals such as magnesium alloys have also been tried to prepare absorbable barrier systems with mechanical properties. Chinese patent CN107164673A discloses an absorbable magnesium alloy repair system for oral guided bone tissue regeneration. Low density, high strength, and low elastic modulus are the performance advantages of magnesium alloys as barrier system materials. However, magnesium has active chemical properties and low electrode potential, which makes magnesium alloy products prone to corrosion. In addition, magnesium has poor room temperature plasticity and is prone to brittle fracture under non-high temperature conditions. At present, no breakthrough has been made in technology. Therefore, due to some inherent performance shortcomings of magnesium metal itself and current technical constraints, it is still difficult to promote and use it widely.

[0006] Therefore, there is an urgent clinical need for a degradable alveolar bone scaffold material with sufficient strength, biocompatibility and osteogenic effect to ensure that the alveolar bone scaffold can be degraded without the need for secondary surgery to remove it, and can also meet the clinical requirements for mechanical properties during the degradation process. Summary of the invention

[0007] In response to the above technical problems, the present invention provides a personalized absorbable tissue isolation system and a preparation method and application thereof, which creatively combines a plate made of degradable material with a membrane to achieve both stable support and tissue isolation.

[0008] To achieve the above object, the technical solution of the present invention is:

[0009] A personalized absorbable tissue isolation system for oral guided bone / tissue regeneration, comprising a tissue isolation plate and a tissue isolation membrane, wherein the tissue isolation membrane is attached to the surface of the tissue isolation plate close to the bone by heat pressing, wherein the tissue isolation plate is mainly made of medical degradable material by injection molding technology, wherein the thickness of the tissue isolation plate is 1.0-2.0 mm, wherein the tissue isolation membrane is made of a mixture of medical degradable material and osteogenic active material by electrospinning, and wherein when an electrospinning solution of a degradable material for electrospinning is prepared, the concentration of the medical degradable material is 5%-20% (w / v), and the concentration of the osteogenic active material is 1%-6% (w / v);

[0010] The molecular weight of the medical degradable material of the tissue isolation plate is 100-250 kDa, and the molecular weight of the medical degradable material of the tissue isolation membrane is 50-200 kDa;

[0011] The glass transition temperature of the personalized absorbable tissue isolation system is 40-60°C;

[0012] The surface of the tissue isolation plate is treated by low-temperature plasma to become a nano-rough surface;

[0013] The personalized absorbable tissue isolation system can be arbitrarily plasticized and cut above the glass transition temperature. In the oral environment, the tissue isolation plate is configured to maintain stable mechanical support during the osteogenesis period, ensure osteogenesis regeneration space, and facilitate bone tissue regeneration. The tissue isolation membrane is configured so that as the medical degradable material degrades, the osteogenic active component participates in osteogenesis;

[0014] The initial bending strength of the personalized absorbable tissue isolation system is at least 80 MPa. After 7 days of in vitro degradation, the bending strength of the personalized absorbable tissue isolation system maintains 85% or more of the initial bending strength. After 14 days of in vitro degradation, the bending strength of the personalized absorbable tissue isolation system maintains 60% or more of the initial bending strength. After 28 days of in vitro degradation, the bending strength of the personalized absorbable tissue isolation system maintains 20%-60% of the initial bending strength.

[0015] In a preferred embodiment of the present invention, the thickness of the tissue isolation membrane is 100-250 μm.

[0016] In a preferred embodiment of the present invention, the medical degradable material is selected from one or more of polylactic acid, polylactic acid-co-glycolic acid, polycaprolactone or polyglycolide;

[0017] The osteogenic active material is selected from one or more of bioactive glass, hydroxyapatite or tricalcium phosphate.

[0018] In a preferred embodiment of the present invention, the microstructure in the tissue isolation membrane has a plurality of disordered nanofibers, so that the tissue isolation membrane has a plurality of holes.

[0019] In a preferred embodiment of the present invention, the edge of the tissue isolation plate is provided with retaining through holes matching the oral fixation pins, and the tissue isolation plate is not provided with the retaining through holes except at the edge.

[0020] Based on the same inventive concept, the present invention also provides a method for preparing a personalized absorbable tissue isolation system, comprising the following steps:

[0021] Preparation of tissue isolation plate: Medical degradable materials are prepared by injection molding technology:

[0022] Preparation of tissue isolation membrane: dissolving a medical degradable material in a solvent to prepare a degradable material solution, adding an osteogenic active material to the prepared degradable material solution to prepare a degradable material electrospinning solution, and then performing electrospinning using an electrospinning technique to prepare the tissue isolation membrane;

[0023] Plasma treatment: After the tissue isolation plate is cleaned and dried, it is placed in a plasma machine for treatment to make the surface of the tissue isolation plate a nano-rough surface;

[0024] Bonding: Bonding the tissue isolation plate and the tissue isolation membrane by heat pressing.

[0025] In a preferred embodiment, in the prepared electrospinning solution of the degradable material, the concentration of the medical degradable material is 5%-20% (w / v), and the concentration of the osteogenic active material is 1%-6% (w / v).

[0026] In a preferred embodiment, the solvent is hexafluoroisopropanol or DMF.

[0027] Based on the same inventive concept, the present invention also provides an application of a personalized absorbable tissue isolation system in the preparation of an oral guided bone / tissue regeneration product.

[0028] Due to the adoption of the above technical solution, the present invention has the following advantages and positive effects compared with the prior art:

[0029] The personalized absorbable tissue isolation system provided by the present invention is applied to guide bone / tissue regeneration in the oral cavity, including a tissue isolation plate and a tissue isolation membrane attached to the surface of the tissue isolation plate close to the bone. The tissue isolation plate and the tissue isolation membrane have both stable support and tissue isolation functions, so as to solve the pain points existing in clinical GBR bone grafting surgery. The tissue isolation plate is fixed to the bone to fix the isolation system to the bone, which can maintain stable mechanical support during the critical period of postoperative osteogenesis, ensure a stable bone regeneration space, and be beneficial to bone tissue regeneration; the tissue isolation membrane is prepared from medical degradable materials and osteogenic active materials, and the osteogenic active components participate in osteogenesis as the medical degradable materials degrade, which is beneficial to osteogenesis. The tissue isolation plate is also prepared from medical degradable materials, so the isolation system can be completely degraded and absorbed in the human body after bone defect healing and reconstruction, without the need for secondary surgery to remove it. Moreover, the glass transition temperature of the isolation system is 40-60℃, and it has reliable support and bending properties at room temperature. It can be plasticized and cut at will above the glass transition temperature to meet personalized needs. Through different material ratios, the glass transition temperature can be adjusted to a temperature condition that is easily achieved during surgery.

[0030] In addition, plasma treatment is used to make the surface of the tissue isolation plate a nano-rough surface. On the one hand, the plasma treatment can effectively improve the hydrophilicity of the material, which is beneficial to the adhesion and growth of gingival soft tissue. On the other hand, the treatment into a nano-rough surface is beneficial for the tissue isolation membrane to fit firmly on the tissue isolation plate.

[0031] Therefore, the isolation system provided by the present invention has both isolation and support functions. Different from the existing metal titanium mesh used in combination with the barrier membrane, the absorbable tissue isolation plate in the present invention does not need to be covered with an additional absorbable membrane.

[0032] The isolation system provided by the present invention is structurally designed based on clinical needs, which is convenient for the operator to perform intraoperative fixation operations. At the same time, the isolation system can be arbitrarily shaped and cut through a guide plate according to the patient's condition during the operation to fit the tissue, thereby avoiding complications caused by unstable fitting after surgery. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 Schematic diagram of the personalized absorbable tissue isolation system of the present invention Figure 1 ;

[0034] Figure 2 for Figure 1 Schematic diagram of AA screenshot;

[0035] Figure 3 Schematic diagram of the personalized absorbable tissue isolation system of the present invention Figure 2 ;

[0036] Figure 4 This is a microscopic morphology of the surface structure of the tissue isolation membrane of Example 1 of the present invention. DETAILED DESCRIPTION

[0037] The personalized absorbable tissue isolation system and its preparation method and application proposed by the present invention are further described in detail below in conjunction with the accompanying drawings and specific embodiments. The advantages and features of the present invention will become more clear according to the following description.

[0038] See also Figure 1-3 , a personalized absorbable tissue isolation system for oral guided bone / tissue regeneration, comprising a tissue isolation plate 1 and a tissue isolation membrane 2, wherein the tissue isolation membrane 2 is attached to the surface of the tissue isolation plate 1 close to the bone, and the tissue isolation plate 1 is mainly made of medical degradable materials, and the thickness is preferably 1.0-2.0 mm. The tissue isolation plate within this thickness range has a reliable supporting effect, and a smaller thickness may not meet the support requirements, and a too thick thickness will increase the difficulty of wound closure and increase the risk of wound dehiscence; usually, a retaining through hole 101 matching the oral fixing pin is provided at the edge of the tissue isolation plate 1, which is used to fix the edge of the isolation system to the bone to achieve the effect of stabilizing the isolation system; no hole is provided in the middle of the absorbable tissue isolation plate to ensure that the absorbable tissue isolation plate has sufficient mechanical support capacity;

[0039] The tissue isolation membrane 2 is prepared by mixing a medical degradable material and an osteogenic active material, and the thickness is preferably 100-250 μm. Within this thickness range, sufficient barrier effect can be obtained without adversely affecting wound healing.

[0040] The glass transition temperature of the personalized absorbable tissue isolation system is 40-60°C.

[0041] The use process of the personalized absorbable tissue isolation system provided by the present invention is as follows: first, bone powder is filled into the alveolar bone defect position; then, a guide plate is bent by a special surgical instrument (the guide plate is usually made of metal material and has a shape and size similar to the actual absorbable tissue isolation system. The doctor places the guide plate at the alveolar bone defect position filled with bone powder by the patient, and uses a special surgical instrument to bend and adjust the position and angle of the guide plate to simulate the installation method of the absorbable tissue isolation system during surgery, thereby improving the accuracy of the surgery), and the shape of the absorbable tissue isolation system to be fixed is confirmed; then, the absorbable tissue isolation system is placed in 60-70°C warm water, and the shaping is completed by the guide plate; finally, the absorbable tissue isolation system is placed in a suitable position, fixed at the fixing through hole with a fixing pin, and the gingival soft tissue is sutured.

[0042] Since one side of the tissue isolation plate is in contact with the tissue isolation membrane and the other side is in contact with the gingival soft tissue, in order to promote the adhesion and growth of the gingival soft tissue to the tissue isolation plate, the surface of the tissue isolation plate is treated with low-temperature plasma to become a nano-rough surface. On the one hand, the plasma treatment can effectively improve the hydrophilicity of the material, which is beneficial to the adhesion and growth of the gingival soft tissue. On the other hand, treatment into a nano-rough surface is beneficial to the tissue isolation membrane to adhere firmly to the tissue isolation plate.

[0043] Preferably, the medical degradable material is selected from one or more of polylactic acid, polylactic acid-co-glycolic acid, polycaprolactone or polyglycolide;

[0044] The osteogenic active material is selected from one or more of bioactive glass, hydroxyapatite or tricalcium phosphate.

[0045] The molecular weight of the medical degradable material of the tissue isolation plate is 100-250kDa, and the molecular weight of the medical degradable material of the tissue isolation membrane is 50-200kDa. By adjusting the molecular weight of the medical degradable material, the degradation time of the absorbable tissue isolation can be moderate, which can not only maintain stable mechanical support during the critical period of postoperative osteogenesis and ensure stable bone regeneration space, but also ensure that it can be completely degraded and absorbed in the human body after bone defect healing and reconstruction, without the need for secondary surgery to remove it.

[0046] The personalized absorbable tissue isolation system provided by the present invention utilizes a tissue isolation plate to fix the isolation system to the bone, which can maintain stable mechanical support during the critical period of postoperative osteogenesis, ensure a stable bone regeneration space, and be beneficial to bone tissue regeneration; the tissue isolation membrane is prepared from medical degradable materials and osteogenic active materials, and the osteogenic active components participate in osteogenesis as the medical degradable materials degrade, which is beneficial to osteogenesis, and further, the tissue isolation membrane has a large porosity due to its fibrous microstructure, which is beneficial to the growth of bone cells. Therefore, the isolation system provided by the present invention has both isolation and support functions, and is different from the existing metal titanium mesh used in conjunction with the barrier membrane, and the absorbable tissue isolation plate in the present invention does not need to be covered with an additional absorbable membrane.

[0047] The isolation system provided by the present invention is structurally designed based on clinical needs, which is convenient for the operator to perform intraoperative fixation operations. At the same time, the isolation system can be arbitrarily shaped and cut through a guide plate according to the patient's condition during the operation to fit the tissue, thereby avoiding complications caused by unstable fitting after surgery.

[0048] Another aspect of the present invention further provides a method for preparing a personalized absorbable tissue isolation system, comprising the following steps:

[0049] Preparation of tissue isolation plate: medical degradable material is prepared by injection molding technology, injection pressure: 600-700 bar, injection temperature: 210-230 ° C, holding pressure: 400-450 bar, holding time: 5-10 s;

[0050] The molecular weight of the medical degradable material is preferably 100-250 kDa, and the thickness of the tissue isolation plate is preferably 1.0-2.0 mm:

[0051] Preparation of tissue isolation membrane: dissolving a medical degradable material in a solvent, stirring evenly in a closed container at room temperature to prepare a degradable material solution; adding an osteogenic active material to the prepared degradable material solution, stirring in a closed container at room temperature to evenly disperse the osteogenic active material in the solution, preparing an electrospinning solution of the degradable material, and then performing electrospinning using an electrospinning technique. After the spinning thickness reaches a preset thickness, vacuum drying the obtained nanofiber membrane to remove excess solvent, and cutting the obtained nanofiber membrane into a suitable size to obtain a tissue isolation membrane. The thickness of the tissue isolation membrane is preferably 100-250 μm;

[0052] Lamination: Align and laminate the tissue isolation plate and the tissue isolation membrane, place them in a fixture, and place the fixture in a vacuum oven for molding. Remove the fixture to obtain a molded absorbable tissue isolation system.

[0053] Preferably, in the prepared electrospinning solution of degradable materials, the concentration of medical degradable materials is 5%-20% (w / v), and the concentration of osteogenic active materials is 1%-6% (w / v). By adjusting the concentration ratio of medical degradable materials and osteogenic active materials, the osteogenic active materials can be controlled to release and promote osteogenesis as the medical degradable materials degrade. At the same time, the molecular weight of the medical degradable materials and the ratio of the medical degradable materials to the osteogenic active materials are adjusted so that the degradation time of the prepared absorbable tissue isolation system is moderate, which can not only maintain stable mechanical support during the critical period of postoperative osteogenesis and ensure stable bone regeneration space; but also can release and promote osteogenesis as the medical degradable materials degrade, and finally be completely degraded and absorbed in the human body, so that the gingival soft tissue can grow into the tooth bone intact.

[0054] Plasma treatment is also included before the bonding step: the tissue isolation plate is cleaned and dried, and then placed in a plasma machine for treatment. It is usually cleaned with ethanol and acetone. The plasma treatment gas is one or more of helium, ammonia, oxygen and nitrogen. The gas flow rate is 20-30sccm, the power is 495-505W, the cavity pressure is 70-80mTorr, and the plasma treatment time is 15-25min. Plasma treatment forms a nano-scale rough structure on the surface of the tissue isolation plate, which increases the hydrophilicity of the tissue isolation plate, facilitates the adhesion and growth of gingival soft tissue, and avoids the risk of complications such as gingival atrophy.

[0055] When preparing the biodegradable material solution, the solvent is an organic solvent that can dissolve the medical biodegradable material and form a polymer solution with a certain viscosity and conductivity, preferably hexafluoroisopropanol or DMF.

[0056] Since the absorbable tissue isolation system can have both barrier and support functions and will not cause gingival atrophy, it can be degraded without the need for secondary surgery to remove it and can meet the clinical requirements for mechanical properties during the degradation process. Therefore, the personalized absorbable tissue isolation system of the present invention can be used in oral guided bone regeneration. Furthermore, the present invention also proposes the use of a personalized absorbable tissue isolation system in the preparation of oral guided bone regeneration surgery products.

[0057] During the GBR surgery, first, bone powder is filled into the alveolar bone defect; then, the guide plate is bent using a special surgical instrument to confirm the shape of the absorbable tissue isolation system to be fixed; then, the absorbable tissue isolation system is placed in 60-70°C warm water, the guide plate is used to complete the shaping, and the appropriate size is cut according to the patient's alveolar bone defect and bone powder filling; finally, the absorbable tissue isolation system is placed in the appropriate position, fixed at the fixing hole with a fixing pin, and the gingival soft tissue is sutured.

[0058] The present invention is described in detail below with reference to specific embodiments.

[0059] Example 1

[0060] Tissue isolation plate: made of polylactic acid with a molecular weight of 100 kDa by injection molding, injection pressure: 600 bar, injection temperature: 230 °C, holding pressure: 450 bar, holding time: 10 s, thickness: 1.0 mm;

[0061] Plasma treatment: The surface was treated with oxygen plasma, gas flow rate: 25sccm, power: 500W, chamber pressure: 75mTorr, plasma treatment time: 20min;

[0062] Tissue isolation membrane: 100 kDa polylactic acid was dissolved in hexafluoroisopropanol solvent to prepare a polylactic acid solution, and then the bioactive glass powder was added to the polylactic acid solution and stirred evenly to prepare an electrospinning solution, wherein the concentration of polylactic acid was 10% (w / v), the concentration of bioactive glass powder was 6% (w / v), and the thickness was 240 μm;

[0063] Bonding: The tissue isolation plate and the tissue isolation membrane are bonded by heat pressing in a vacuum oven. The prepared tissue isolation membrane is tested by scanning electron microscopy (SEM) to obtain the surface microstructure, such as Figure 4 As shown, the fiber membrane has a disordered structure and therefore has a large porosity, which is conducive to the growth of bone cells;

[0064] The glass transition temperature of the tissue isolation system prepared in this embodiment was tested to be 55°C.

[0065] Example 2

[0066] Tissue isolation plate: made of polylactic acid with a molecular weight of 250 kDa by injection molding, injection pressure: 700 bar, injection temperature: 210 ° C, holding pressure: 400 bar, holding time: 5 s, thickness: 2.0 mm;

[0067] Plasma treatment: The surface is treated with oxygen plasma, gas flow: 25sccm, power: 500W, chamber pressure: 75mTorr, plasma treatment time: 20min;

[0068] Tissue isolation membrane: 180 kDa polylactic acid was dissolved in hexafluoroisopropanol solvent to prepare a polylactic acid solution, and then the bioactive glass powder was added to the polylactic acid solution and stirred evenly to prepare an electrospinning solution, wherein the concentration of polylactic acid was 6% (w / v), the concentration of bioactive glass powder was 3% (w / v), and the thickness was 100 μm;

[0069] Bonding: The tissue isolation plate and the tissue isolation membrane are bonded together by heat pressing in a vacuum oven.

[0070] The glass transition temperature of the tissue isolation system prepared in this embodiment was tested to be 60°C.

[0071] Example 3

[0072] Tissue isolation plate: made of polylactic acid-glycolic acid copolymer (PLGA, LA:GA=75:25) with a molecular weight of 100 kDa by injection molding, injection pressure: 700 bar, injection temperature: 230°C, holding pressure: 400 bar, holding time: 10 s, thickness: 2.0 mm;

[0073] Plasma treatment: The surface is treated with oxygen plasma, gas flow: 25sccm, power: 500W, chamber pressure: 75mTorr, plasma treatment time: 20min;

[0074] Tissue isolation membrane: 100 kDa polylactic acid was dissolved in hexafluoroisopropanol solvent to prepare a polylactic acid solution, and then the bioactive glass powder was added to the polylactic acid solution and stirred evenly to prepare an electrospinning solution, wherein the concentration of polylactic acid was 10% (w / v), the concentration of bioactive glass powder was 3% (w / v), and the thickness was 200 μm;

[0075] Bonding: The tissue isolation plate and the tissue isolation membrane are bonded together by heat pressing in a vacuum oven.

[0076] The glass transition temperature of the tissue isolation system prepared in this embodiment was tested to be 45°C.

[0077] Example 4

[0078] Tissue isolation plate: made of polyglycolide (PGA) with a molecular weight of 100 kDa by injection molding, injection pressure: 700 bar, injection temperature: 230 ° C, holding pressure: 450 bar, holding time: 10 s, thickness: 1.5 mm;

[0079] Plasma treatment: The surface is treated with oxygen plasma, gas flow: 25sccm, power: 500W, chamber pressure: 75mTorr, plasma treatment time: 20min;

[0080] Tissue isolation membrane: 70 kDa polylactic acid was dissolved in hexafluoroisopropanol solvent to prepare a polylactic acid solution, and then the bioactive glass powder was added to the polylactic acid solution and stirred evenly to prepare an electrospinning solution, wherein the concentration of polylactic acid was 20% (w / v), the concentration of bioactive glass powder was 6% (w / v), and the thickness was 210 μm;

[0081] Bonding: The tissue isolation plate and the tissue isolation membrane are bonded together by heat pressing in a vacuum oven.

[0082] The glass transition temperature of the tissue isolation system prepared in this embodiment was tested to be 40°C.

[0083] 1. Bending strength test structure at different degradation time points

[0084] The absorbable tissue isolation systems obtained in Example 1, Example 2, Example 3, and Example 4 were subjected to in vitro real-time degradation tests at 37°C according to the requirements of YY / T1806.1-2021 "In vitro degradation performance evaluation method for biomedical materials Part 1: degradable polyesters". Samples were taken at 0 days, 7 days, 14 days, 28 days, and 90 days of degradation, and the bending strength test was carried out with reference to the test method of GB / T 9341-2008 "Determination of flexural properties of plastics". The test results are shown in Table 1.

[0085] Table 1. Bending strength test results at different degradation time points

[0086]

[0087] As shown in Table 1, the absorbable tissue isolation system made of PLA in Example 1-2 can maintain mechanical properties for at least 90 days in the in vitro degradation experiment, and the molecular weight of PLA has no significant effect on the initial bending strength, but the larger the molecular weight, the slower the degradation, so at the same degradation time, the greater the molecular weight of PLA, the smaller the loss of bending strength; after being treated with 70°C warm water for 10s and hardened at room temperature, there is no significant effect on the bending strength of the product, indicating that when the tissue isolation system is applied, the room temperature hardening after warm water treatment will not affect its bending strength. The absorbable tissue isolation system made of PLGA (Example 3) degrades faster, but it can still maintain certain mechanical properties on the 28th day of degradation. The initial bending performance of the absorbable tissue isolation system made of PGA (Example 4) is higher than that of PLA, but it degrades faster and has a shorter mechanical maintenance time, but it can still maintain certain mechanical properties on the 28th day of degradation. The degradation time and bending strength of Examples 2 and 3 and Examples 1, 2, 3 and 4 show that after 7 days of in vitro degradation, the bending strength of the isolation system can still maintain 85% or more of the initial bending strength, and after 14 days of in vitro degradation, the bending strength of the personalized absorbable tissue isolation system can still maintain 60% or more of the initial bending strength. The bending strength after 28 days of in vitro degradation is related to the type and molecular weight of the selected degradable material. For example, Example 2 uses high molecular weight polylactic acid PLA, and its bending strength can still maintain 60% of the initial strength after 28 days of degradation, and can still maintain 20% of the bending strength after 90 days of degradation; however, Examples 3 and 4 using PLGA or PGA have mechanical properties that have dropped to 20%-30% after 28 days of degradation, and cannot be tested after 90 days of degradation. Therefore, the degradation time and bending strength can be adjusted by adjusting the type, molecular weight, thickness of the tissue isolation plate, and the concentration of the medical degradable material and the concentration of the osteogenic active material when preparing the tissue isolation membrane, and can be flexibly set according to the patient's condition in actual application.

[0088] 2. Hydrophilicity test

[0089] The surface contact angles of the tissue isolation plate (on the gingival side) in the absorbable tissue isolation system obtained in Examples 1-4, the polylactic acid plate, the polylactic acid-glycolic acid copolymer plate and the polyglycolide plate using the same injection molding process but not plasma treated were measured at room temperature using a contact angle tester. Three samples were tested in each group of samples, and three positions were tested on each sample. The average value was calculated. The test results are shown in Table 2.

[0090] Table 2. Contact angle test results

[0091] Serial number Contact Angle Example 1 44.67°±2.16° Example 2 45.27°±1.55° Example 3 41.06°±1.35° Example 4 43.78°±1.24° Polylactic acid without plasma treatment 92.75°±3.64° Poly(lactic-co-glycolic acid) without plasma treatment 80.28°±1.92° Polyglycolide without plasma treatment 87.14°±1.59°

[0092] It can be seen from Table 2 that the hydrophilicity of the injection-molded medical degradable material tissue isolation plates after plasma treatment has been improved, among which the PLA surface has changed from hydrophobic (>90°) to hydrophilic (45°). The literature [Zhang Bo, Wang Xiaofeng, Guo Meng, et al. Study on surface carboxylation modification and cell compatibility of polylactic acid [J]. China Plastics, 2021, 035(005): 17-23.] shows that endothelial cells exhibit good adhesion on surfaces with contact angles of 40°-60°. Therefore, it is believed that plasma treatment improves the hydrophilicity of PLA in Examples 1-2, which is beneficial to endothelial cell adhesion; while the contact angles of Example 3 relative to PLGA without plasma treatment and Example 4 relative to PGA without plasma treatment are reduced, which also shows that plasma treatment improves the hydrophilicity of PLGA and PGA. Therefore, plasma treatment can moderately improve the hydrophilicity of the part of the absorbable tissue isolation plate that contacts the gums, which is beneficial to endothelial cell adhesion and avoids gum atrophy.

[0093] The present invention innovatively adopts a design combining an isolation plate and a membrane to prepare an absorbable tissue isolation system with both stable support and tissue isolation. The tissue isolation plate with mechanical properties is prepared by injection molding using medical degradable materials, which can ensure a stable osteogenic space for a period of time after surgery and is conducive to bone tissue regeneration; the tissue isolation membrane is prepared by electrostatic spinning using medical degradable materials composited with osteogenic active materials (hydroxyapatite, bioglass, etc.), and the osteogenic active materials are conducive to osteogenesis. Finally, the membrane and the plate are bonded together by hot pressing to complete the preparation of the absorbable tissue isolation system with an outer plate and an inner membrane.

[0094] The absorbable tissue isolation plate prepared by injection molding is innovatively treated with plasma surface etching to form a nano-scale micro-rough structure on the surface of the tissue isolation plate, thereby increasing the hydrophilicity of the absorbable polyester plate, facilitating the adhesion and growth of gingival soft tissue, thereby avoiding the risk of complications such as gingival atrophy, and increasing the bonding strength between the tissue isolation plate and the tissue isolation membrane.

[0095] By adjusting the molecular weight of medical degradable materials and the ratio of medical degradable materials to osteogenic active materials, the degradation time of the prepared absorbable tissue isolation system is moderate. On the one hand, it can maintain stable mechanical support during the critical period of postoperative osteogenesis and ensure stable bone regeneration space; on the other hand, the absorbable tissue isolation system can be completely degraded and absorbed in the human body after bone defect healing and reconstruction, without the need for a secondary operation to remove it.

[0096] The absorbable tissue isolation plate of the present invention is structurally designed based on clinical needs, which is convenient for the surgeon to perform intraoperative fixation operations. At the same time, it can be arbitrarily shaped and cut through the guide plate according to the patient's condition during the operation to fit the tissue, thereby avoiding complications caused by unstable fitting after surgery.

[0097] The embodiments of the present invention are described in detail above in conjunction with the accompanying drawings, but the present invention is not limited to the above embodiments. Even if various changes are made to the present invention, if these changes fall within the scope of the claims of the present invention and their equivalents, they still fall within the protection scope of the present invention.

Claims

1. A personalized absorbable tissue isolation system for guided bone / tissue regeneration in large alveolar bone defects in the oral cavity, characterized in that: It comprises a tissue isolation plate and a tissue isolation membrane, wherein the tissue isolation membrane is attached to the surface of the tissue isolation plate close to the bone by heat pressing, the tissue isolation plate is mainly made of medical degradable material by injection molding technology, the thickness of the tissue isolation plate is 1.0-2.0 mm, the tissue isolation membrane is made of medical degradable material mixed with osteogenic active material by electrostatic spinning, and when the electrospinning solution of degradable material for electrostatic spinning is prepared, the concentration of the medical degradable material is 5%-20% (w / v), and the concentration of the osteogenic active material is 1%-6% (w / v); The molecular weight of the medical degradable material of the tissue isolation plate is 100-250 kDa, and the molecular weight of the medical degradable material of the tissue isolation membrane is 50-200 kDa; the glass transition temperature of the personalized absorbable tissue isolation system is 40-60°C; The surface of the tissue isolation plate is treated by low-temperature plasma to become a nano-rough surface; The personalized absorbable tissue isolation system can be arbitrarily plasticized and cut above the glass transition temperature. In the oral environment, the tissue isolation plate is configured to maintain stable mechanical support during the osteogenesis period, ensure osteogenesis regeneration space, and facilitate bone tissue regeneration. The tissue isolation membrane is configured so that as the medical degradable material degrades, the osteogenic active component participates in osteogenesis; The initial bending strength of the personalized absorbable tissue isolation system is at least 80 MPa. After 7 days of in vitro degradation, the bending strength of the personalized absorbable tissue isolation system maintains 85% or more of the initial bending strength. After 14 days of in vitro degradation, the bending strength of the personalized absorbable tissue isolation system maintains 60% or more of the initial bending strength. After 28 days of in vitro degradation, the bending strength of the personalized absorbable tissue isolation system maintains 20%-60% of the initial bending strength.

2. The personalized absorbable tissue isolation system according to claim 1, characterized in that: The thickness of the tissue isolation membrane is 100-250 μm.

3. The personalized absorbable tissue isolation system according to claim 1, characterized in that: The medical degradable material is selected from one or more of polylactic acid, polylactic acid-co-glycolic acid, polycaprolactone or polyglycolide; The osteogenic active material is selected from one or more of bioactive glass, hydroxyapatite or tricalcium phosphate.

4. The personalized absorbable tissue isolation system according to claim 1, characterized in that: The microstructure in the tissue isolation membrane has a plurality of disordered nanofibers, so that the tissue isolation membrane has a plurality of holes.

5. The personalized absorbable tissue isolation system according to claim 1, characterized in that: The edge of the tissue isolation plate is provided with a retaining through hole matching the oral fixation nail, and the tissue isolation plate is not provided with the retaining through hole except at the edge position.

6. A method for preparing the personalized absorbable tissue isolation system according to any one of claims 1 to 5, characterized in that: The following steps are involved: Preparation of tissue isolation plate: Medical degradable materials are prepared by injection molding technology: Preparation of tissue isolation membrane: dissolving a medical degradable material in a solvent to prepare a degradable material solution, adding an osteogenic active material to the prepared degradable material solution to prepare a degradable material electrospinning solution, and then performing electrospinning using an electrospinning technique to prepare the tissue isolation membrane; Plasma treatment: After the tissue isolation plate is cleaned and dried, it is placed in a plasma machine for treatment to make the surface of the tissue isolation plate a nano-rough surface; Bonding: Bonding the tissue isolation plate and the tissue isolation membrane by heat pressing.

7. The method for preparing the personalized absorbable tissue isolation system according to claim 6, characterized in that: In the prepared electrospinning solution of the degradable material, the concentration of the medical degradable material is 5%-20% (w / v), and the concentration of the osteogenic active material is 1%-6% (w / v).

8. The method for preparing the personalized absorbable tissue isolation system according to claim 7, characterized in that: The solvent is hexafluoroisopropanol or DMF.

9. Use of the personalized absorbable tissue isolation system according to any one of claims 1 to 5 in the preparation of oral guided bone / tissue regeneration products.